|
Active genes
|
|
/p
|
|
/p
|
|---|
|
Leukemia
|
624
|
17.474%
|
18
|
0.504%
|
|
Breast cancer
|
128
|
1.803%
|
9
|
0.130%
|
|
Prostate
|
949
|
15.730%
|
16
|
0.265%
|
|
Colon
|
1028
|
51.400%
|
12
|
0.600%
|
|
SRBCT
|
68
|
2.946%
|
11
|
0.477%
|
|
Lymphoma
|
279
|
6.930%
|
19
|
0.472%
|
|
Brain
|
345
|
6.164%
|
21
|
0.375%
|
|
NCI
|
227
|
4.329%
|
23
|
0.439%
|
- Number and proportion of genes that ever have been used in the first cluster
(first two columns), as well as number and proportion of genes that have been used for cluster in more than 50 out of the 1000 bootstrap trials (last two columns). The selection of data is identical to Table 8.
(first two columns), as well as number and proportion of genes that have been used for cluster